Mostrar el registro sencillo del ítem
| dc.contributor.author | Burgos-Pelaez, Rosa | |
| dc.contributor.author | Escudero-Alvarez, Elena | |
| dc.contributor.author | García-Almeida, José-Manuel | |
| dc.contributor.author | García-de-Lorenzo, Abelardo | |
| dc.contributor.author | García-Luna, Pedro-Pablo | |
| dc.contributor.author | Gil-Hernández, Angel | |
| dc.contributor.author | Matos-Adames, Alfredo | |
| dc.contributor.author | Molina-Soria, Juan-Bautista | |
| dc.contributor.author | Montejo-González, Juan-Carlos | |
| dc.contributor.author | Sánchez-Álvarez, Carmen | |
| dc.contributor.author | Perez-de-la-Cruz, Antonio | |
| dc.date.accessioned | 2026-10-21T06:12:18Z | |
| dc.date.available | 2026-10-21T06:12:18Z | |
| dc.date.issued | 2015-08-01 | |
| dc.identifier.citation | Burgos Peláez R, Escudero Álvarez E, García Almeida JM, García de Lorenzo A, García Luna PP. Farmaconutrición en el paciente grave. Nutrición Hospitalaria. 1 de agosto de 2015;(2):478-86. doi:10.3305/nh.2015.32.2.9324 | |
| dc.identifier.issn | 0212-1611 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/28748 | |
| dc.description.abstract | Pharmaconutrient is a term applicable to those compounds which. in addition to their nutritional function, play a role as aids in the treatment of patients with severe pathologies, including sepsis, trauma, burns and major surgery, In general, enrichment of enteral an parenteral formulas with pharmaconutrients contribute to positively modulate the inflammatory response, infection and controlling the internal milieu, which in turn can be evaluated through lower mortality, hospital and intensive care units stay, days of mechanical ventilation and other parameters allowing to asses their effects. Arginine, glutamine, nucleotides, omega-3 fatty acids and antioxidant micronutrients, make up the nucleus of pharmaconutrients used with that aim, usually as mixtures of them. In the present review current evidence about the effects, indications, limitations, doses, potential adverse risks and even counter-indications is analysed. | |
| dc.language.iso | spa | |
| dc.rights | Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internaciona | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | * |
| dc.subject.mesh | Critical Care/methods | |
| dc.subject.mesh | Critical Illness/therapy | |
| dc.subject.mesh | Drug Therapy | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Intensive Care Units | |
| dc.subject.mesh | Nutrition Therapy | |
| dc.subject.mesh | Parenteral Nutrition | |
| dc.title | Farmaconutrición en el paciente grave | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 26268074 | |
| dc.relation.publisherversion | https://doi.org/10.3305/nh.2015.32.2.9324 | |
| dc.type.version | info:eu-repo/semantics/publishedVersion | |
| dc.identifier.doi | 10.3305/nh.2015.32.2.9324 | |
| dc.journal.title | Nutrición Hospitalaria | |
| dc.identifier.essn | 1699-5198 |